Advertisement

Dermatology and Pruritus Ani

  • Charles O. Finne
  • John R. Fenyk
Chapter

Abstract

Perianal skin is subject to virtually all of the diseases that affect skin and mucosa. The differential diagnosis of disease in perianal skin is broad (Table 16-1) and includes a variety of diagnoses. These diseases almost never present solely within the perianal area; however, there are common diseases such as psoriasis that may present in the perianal area without obvious ties to other areas of the body unless a careful search is made. Certain diseases have specific causes and well-recognized treatment protocols (e.g., psoriasis, candida, and Bowen’s disease), other diseases have less well-defined causes and all too often where therapy is established it is poorly defined. Recognition of important treatable causes requires a disciplined, organized approach to diagnosis with careful and complete history, physical exam, and the frequent use of biopsy. This chapter’s objective is to lay out a strategy to facilitate accurate diagnosis and successful treatment of perianal and anal skin conditions.

Keywords

Atopic Dermatitis Allergic Contact Dermatitis Topical Steroid Mometasone Furoate Lichen Sclerosus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Corman ML. Colon and rectal surgery. 2nd ed. Philadelphia, PA: Lippincott; 1989. p. 287.Google Scholar
  2. 2.
    Daniel GL, Longo WE, Vernava III AM. Pruritus ani causes and concerns. Dis Colon Rectum. 1994;37:670–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Verbov J. Pruritus ani and its management – a study and reappraisal. Clin Exp Dermatol. 1984;9:46–52.PubMedCrossRefGoogle Scholar
  4. 4.
    Bernhard JD. Itch: mechanisms and management of pruritus. New York: McGraw-Hill; 1994.Google Scholar
  5. 5.
    Davidson S, Zhang X, Yoon CH, Khasabov SG, Simone DA, Giesler Jr GJ. The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci. 2007;27:10007–14.PubMedCrossRefGoogle Scholar
  6. 6.
    Johanek LM, Meyer RA, Hartke T, Hobelmann JG, Maine DN, LaMotte RH, et al. Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. J Neurosci. 2007;27:7490–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Stander S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol. 2008;17:161–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Stamos MJ, Hicks TC, Pruritus ani: diagnosis and treatment. In: Perspectives in Colon and Rectal Surgery, 1998;11(1):1–20. Thieme Medical Publishers.Google Scholar
  9. 9.
    Bernhard JD, Kligman AM, Shelley WB. Dermographic pruritus: invisible dermographism. J Am Acad Dermatol. 1995;33:322.PubMedCrossRefGoogle Scholar
  10. 10.
    Sherertz EF. Clinical pearl: symptomatic dermatographism as a cause of genital pruritus. J Am Acad Dermatol. 1994;31:1040–1.PubMedCrossRefGoogle Scholar
  11. 11.
    Caplan RM. The irritant role of feces in the genesis of perianal itch. Gastroenterology. 1966;50:19–23.PubMedGoogle Scholar
  12. 12.
    Smith LE, Henrichs D, McCullah RD. Prospective studies on the etiology and treatment of pruritus ani. Dis Colon Rectum. 1982;25:358–63.PubMedCrossRefGoogle Scholar
  13. 13.
    Allan A, Ambrose NS, Silverman S, Keighley MR. Physiological study of pruritus ani. Br J Surg. 1987;74:576–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Farouk R, Duthie GS, Pryde A, Bartolo DC. Abnormal transient internal sphincter relaxation in idiopathic pruritus ani: physiological evidence from ambulatory monitoring. Br J Surg. 1994;81:603–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Eyers AA, Thomson JP. Pruritus ani: is anal sphincter dysfunction important in aetiology? Br Med J. 1979;2:1549–51.PubMedCrossRefGoogle Scholar
  16. 16.
    Dodi G, Pirone E, Bettin A, Veller C, Infantino A, Pianon P, et al. The mycotic flora in proctological patients with and without pruritus ani. Br J Surg. 1985;72:967–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Alexander S. Dermatological aspects of anorectal disease. Clin Gastroenterol. 1975;4:651–7.PubMedGoogle Scholar
  18. 18.
    Pirone E, Infantino A, Masin A, Melega F, Pianon P, Dodi G, et al. Can proctological procedures resolve perianal pruritus and mycosis? A prospective study of 23 cases. Int J Colorectal Dis. 1992;7:18–20.PubMedCrossRefGoogle Scholar
  19. 19.
    Bowyer A, McColl I. A study of 200 patients with pruritus ani. Proc R Soc Med. 1970;63(Suppl):96–8.PubMedGoogle Scholar
  20. 20.
    Weismann K, Sand Petersen C, Roder B. Pruritus ani caused by beta-haemolytic streptococci. Acta Derm Venereol. 1996;76:415.PubMedGoogle Scholar
  21. 21.
    Bowyer A, McColl I. Erythrasma and pruritus ani. Acta Derm Venereol. 1971;51:444–7.PubMedGoogle Scholar
  22. 22.
    Sindhuphak W, MacDonald E, Smith EB. Erythrasma. Overlooked or misdiagnosed? Int J Dermatol. 1985;24:95–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Baral J. Pruritus ani and Staphylococcus aureus. J Am Acad Dermatol. 1983;9:962.PubMedCrossRefGoogle Scholar
  24. 24.
    Dasan S, Neill SM, Donaldson DR, Scott HJ. Treatment of persistent pruritus ani in a combined colorectal and dermatological clinic. Br J Surg. 1999;86:1337–40.PubMedCrossRefGoogle Scholar
  25. 25.
    Habif TP. Clinical dermatology: a color guide to diagnosis and therapy. 3rd ed. St. Louis: Mosby; 1996.Google Scholar
  26. 26.
    Harrington CI, Lewis FM, McDonagh AJ, Gawkrodger DJ. Dermatological causes of pruritus ani. BMJ. 1992;305:955.PubMedCrossRefGoogle Scholar
  27. 27.
    Bruynzeel DP. Dermatological causes of pruritus ani. BMJ. 1992;305:955.PubMedCrossRefGoogle Scholar
  28. 28.
    Rohde H. Routine anal cleansing, so-called hemorrhoids, and perianal dermatitis: cause and effect? Dis Colon Rectum. 2000;43:561–3.PubMedCrossRefGoogle Scholar
  29. 29.
    Lochridge Jr E. Pruritus ani – perianal psoriasis. South Med J. 1969;62:450–2.PubMedCrossRefGoogle Scholar
  30. 30.
    Habif TP. Clinical dermatology: a color guide to diagnosis and therapy. 4th ed. Philadelphia, Pa: Mosby, 2004.Google Scholar
  31. 31.
    Wang G, Li C, Gao T, Liu Y. Clinical analysis of 48 cases of inverse psoriasis: a hospital-based study. Eur J Dermatol. 2005;15:176–8.PubMedGoogle Scholar
  32. 32.
    Kalb RE, Bagel J, Korman NJ, Lebwohl MG, Young M, Horn EJ, et al. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;60:120–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet. 2006;38:337–42.PubMedCrossRefGoogle Scholar
  34. 34.
    Segre JA. Epidermal differentiation complex yields a secret: mutations in the cornification protein filaggrin underlie ichthyosis vulgaris. J Invest Dermatol. 2006;126:1202–4.PubMedCrossRefGoogle Scholar
  35. 35.
    Segre JA. Epidermal barrier formation and recovery in skin disorders. J Clin Invest. 2006;116:1150–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol. 1995;32:393–416. quiz 417–398.PubMedCrossRefGoogle Scholar
  37. 37.
    Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol. 2002;147:640–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353:1777–83.PubMedCrossRefGoogle Scholar
  39. 39.
    Wong YW, Powell J, Oxon MA. Lichen sclerosus: a review. Minerva Med. 2002;93:95–9.PubMedGoogle Scholar
  40. 40.
    Byren I, Venning V, Edwards A. Carcinoma of the vulva and asymptomatic lichen sclerosus. Genitourin Med. 1993;69:323–4.PubMedGoogle Scholar
  41. 41.
    Carli P, Cattaneo A, De Magnis A, Biggeri A, Taddei G, ­Giannotti B. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev. 1995;4:491–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Carli P, De Magnis A, Mannone F, Botti E, Taddei G, ­Cattaneo A. Vulvar carcinoma associated with lichen sclerosus. Experience at the Florence, Italy, Vulvar Clinic. J Reprod Med. 2003;48:313–8.PubMedGoogle Scholar
  43. 43.
    Val I, Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol. 2005;48:808–17.PubMedCrossRefGoogle Scholar
  44. 44.
    Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther. 2004;17:28–37.PubMedCrossRefGoogle Scholar
  45. 45.
    Assmann T, Becker-Wegerich P, Grewe M, Megahed M, ­Ruzicka T. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol. 2003;48:935–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Bohm M, Frieling U, Luger TA, Bonsmann G. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol. 2003;139:922–4.PubMedCrossRefGoogle Scholar
  47. 47.
    Friend WG. The cause and treatment of idiopathic pruritus ani. Dis Colon Rectum. 1977;20:40–2.PubMedCrossRefGoogle Scholar
  48. 48.
    Akl K. Yogurt-induced pruritus ani in a child. Eur J Pediatr. 1992;151:867.PubMedCrossRefGoogle Scholar
  49. 49.
    Murie JA, Sim AJ, Mackenzie I. The importance of pain, pruritus and soiling as symptoms of haemorrhoids and their response to haemorrhoidectomy or rubber band ligation. Br J Surg. 1981;68:247–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Koblenzer CS. Psychologic and psychiatric aspects of itching. In: Bernhard JD, editor. Itch: mechanisms and management of pruritus. New York: McGraw-Hill; 1994. p. 347–65.Google Scholar
  51. 51.
    Andrews D, Grunau VJ. An uncommon adverse effect following bolus administration of intravenous dexamethasone. J Can Dent Assoc. 1986;52:309–11.PubMedGoogle Scholar
  52. 52.
    Kligman AM, Frosch PJ. Steroid addiction. Int J Dermatol. 1979;18:23–31.PubMedCrossRefGoogle Scholar
  53. 53.
    Goldman L, Kitzmiller KW. Perianal atrophoderma from topical corticosteroids. Arch Dermatol. 1973;107:611–2.PubMedCrossRefGoogle Scholar
  54. 54.
    Alexander-Williams J. Pruritus ani. Br Med J (Clin Res Ed). 1983;287:159–60.CrossRefGoogle Scholar
  55. 55.
    Dibb WL. In vitro efficacy of Otic Domeboro against Pseudomonas aeruginosa. Undersea Biomed Res. 1985;12:307–13.PubMedGoogle Scholar
  56. 56.
    Thorp MA, Gardiner IB, Prescott CA. Burow’s solution in the treatment of active mucosal chronic suppurative otitis media: determining an effective dilution. J Laryngol Otol. 2000;114:432–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Thorp MA, Kruger J, Oliver S, Nilssen EL, Prescott CA. The antibacterial activity of acetic acid and Burow’s solution as topical otological preparations. J Laryngol Otol. 1998;112:925–8.PubMedGoogle Scholar
  58. 58.
    Thorp MA, Oliver SP, Kruger J, Prescott CA. Determination of the lowest dilution of aluminium acetate solution able to inhibit in vitro growth of organisms commonly found in chronic suppurative otitis media. J Laryngol Otol. 2000;114:830–1.PubMedCrossRefGoogle Scholar
  59. 59.
    Helwig EB, Graham JH. Anogenital (extramammary) ­Paget’s disease: a clinicopathological study. Cancer. 1963;16:387–403.PubMedCrossRefGoogle Scholar
  60. 60.
    Jensen SL, Sjolin KE, Shokouh-Amiri MH, Hagen K, ­Harling H. Paget’s disease of the anal margin. Br J Surg. 1988;75:1089–92.PubMedCrossRefGoogle Scholar
  61. 61.
    Sarmiento JM, Wolff BG, Burgart LJ, Frizelle FA, Ilstrup DM. Paget’s disease of the perianal region – an aggressive disease? Dis Colon Rectum. 1997;40:1187–94.PubMedCrossRefGoogle Scholar
  62. 62.
    Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC. ­Perianal Bowen’s disease: a clinicopathologic study of 47 patients. Dis Colon Rectum. 1997;40:1286–93.PubMedCrossRefGoogle Scholar
  63. 63.
    Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum. 2002;45:453–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Goldstone SE, Winkler B, Ufford LJ, Alt E, Palefsky JM. High prevalence of anal squamous intraepithelial lesions and squamous-cell carcinoma in men who have sex with men as seen in a surgical practice. Dis Colon Rectum. 2001;44:690–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Brady MS, Kavolius JP, Quan SH. Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum. 1995;38:146–51.PubMedCrossRefGoogle Scholar
  66. 66.
    Enker WE, Heilwell M, Janov AJ, Quan SH, Magill G, Stearns Jr MW, et al. Improved survival in epidermoid carcinoma of the anus in association with preoperative multidisciplinary therapy. Arch Surg. 1986;121:1386–90.PubMedGoogle Scholar
  67. 67.
    Goldman S, Glimelius B, Pahlman L. Anorectal malignant melanoma in Sweden. Report of 49 patients. Dis Colon Rectum. 1990;33:874–7.PubMedCrossRefGoogle Scholar
  68. 68.
    McClatchey KD. Clinical laboratory medicine. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.Google Scholar
  69. 69.
    Kerscher MJ, Korting HC. Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis. Skin Pharmacol. 1992;5:77–80.PubMedCrossRefGoogle Scholar
  70. 70.
    Hoffmann K, Auer T, Stucker M, Hoffmann A, Altmeyer P. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone. J Eur Acad Dermatol Venereol. 1998;10:137–42.PubMedCrossRefGoogle Scholar
  71. 71.
    Kerscher MJ, Korting HC. Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound. Acta Derm Venereol. 1992;72:214–6.PubMedGoogle Scholar
  72. 72.
    Robinson N, Singri P, Gordon KB. Safety of the new macrolide immunomodulators. Semin Cutan Med Surg. 2001;20:242–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Becker EM, Koo JY. Clinical focus: the spectrum of topical agents for the treatment of psoriasis. Medscape CME; 2009Google Scholar
  74. 74.
    Ling MR. Topical tacrolimus and pimecrolimus: future directions. Semin Cutan Med Surg. 2001;20:268–74.PubMedCrossRefGoogle Scholar
  75. 75.
    Wolloch Y, Dintsman M. A simple and effective method of treatment for intractable pruritus ani. Am J Proctol Gastroenterol Colon Rectal Surg. 1979;30:34–6.PubMedGoogle Scholar
  76. 76.
    Eusebio EB, Graham J, Mody N. Treatment of intractable pruritus ani. Dis Colon Rectum. 1990;33:770–2.PubMedCrossRefGoogle Scholar
  77. 77.
    Eusebio EB. New treatment of intractable pruritus ani. Dis Colon Rectum. 1991;34:289.PubMedCrossRefGoogle Scholar
  78. 78.
    Farouk R, Lee PW. Intradermal methylene blue injection for the treatment of intractable idiopathic pruritus ani. Br J Surg. 1997;84:670.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Charles O. Finne
    • 1
  • John R. Fenyk
    • 2
  1. 1.Division of Colon and Rectal Surgery, Department of SurgeryUniversity of Minnesota Medical SchoolMinneapolisUSA
  2. 2.Department of DermatologyUniversity of Minnesota Medical SchoolMinneapolisUSA

Personalised recommendations